To hear about similar clinical trials, please enter your email below
Trial Title:
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
NCT ID:
NCT05918549
Condition:
Motion Analysis in Musculoskeletal Oncology
Conditions: Official terms:
Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Device
Intervention name:
Motion Analysis in Musculoskeletal Oncology
Description:
Noninterventional, prospective, multicenter pilot study of patients with primary and
secondary musculoskeletal tumors designed to investigate functional outcomes after
therapy using both subjective and quantitative motion detection techniques
Arm group label:
Popolation
Summary:
Noninterventional, prospective, multicenter pilot study of patients with primary and
secondary musculoskeletal tumors designed to investigate functional outcomes after
therapy using both subjective and quantitative motion detection techniques
Criteria for eligibility:
Study pop:
Patients with primary and secondary cancers of the musculoskeletal system with estimated
survival greater than one year who are candidates for bone resection surgery or wide
excision of soft tissue lesion and/or radio and chemotherapy treatments
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age > 6 years
- Diagnosis of primary and secondary tumors of the musculoskeletal system
- Patients who will need to undergo surgery for bone resection or wide excision of
soft tissue lesion, and/or radiation or drug treatments
- Availability of follow-up data (for at least 6 months)
- Written informed consent
Exclusion Criteria:
- Inability to perform pre-post treatment assessment
Gender:
All
Minimum age:
6 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
"Regina Elena" National Cancer Institute
Address:
City:
Rome
Zip:
00144
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Roberto Biagini, MD
Phone:
ND
Email:
roberto.biagini@ifo.it
Start date:
September 28, 2022
Completion date:
September 28, 2024
Lead sponsor:
Agency:
Regina Elena Cancer Institute
Agency class:
Other
Collaborator:
Agency:
Azienda Policlinico Umberto I
Agency class:
Other
Collaborator:
Agency:
Università degli studi di Roma Foro Italico
Agency class:
Other
Source:
Regina Elena Cancer Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05918549
